927-P: Sodium–Glucose Cotransporter 2 Inhibitors Use during Ramadan in People with Type 1 Diabetes-Observational Study

Introduction & Objective: Sodium-glucose cotransporter-2 (SGLT2) inhibitors represent a novel class of anti-hyperglycemic agents with added benefit of renal protection. Their use in type 1 diabetes is limited. During Ramadan Muslims fast from sunset to sunrise, abstaining from both food and drin...

Full description

Bibliographic Details

Published in:	Diabetes (New York, N.Y.) Vol. 73; p. 1
Main Authors:	Alozairi, Ebaa S, Irshad, Mohammad, Sojan, Litty G, Alroudhan, Dherar, Taghadom, Etab, Alkandari, Jumana
Format:	Journal Article
Language:	English
Published:	New York American Diabetes Association 01-06-2024
Subjects:	Adverse events Clinical trials Dehydration Diabetes Diabetes mellitus (insulin dependent) Fasting Glucose Glucose monitoring Hypoglycemia Ketoacidosis Observational studies Ramadan Sodium-glucose cotransporter
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!